Advances in the understanding and treatment of biliary atresia

Current Opinion in Pediatrics

Volumn 20, Issue 3, 2008, Pages 315-319

  Roach, Jonathan P ^a   Bruny, Jennifer L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

Biliary atresia; Innate immunity; Outcomes; Steroids

Indexed keywords

BILIRUBIN; CORTICOSTEROID; PREDNISOLONE;

BILE DUCT ATRESIA; BILIARY TRACT SURGERY; BILIRUBIN BLOOD LEVEL; COMPARATIVE STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DECENTRALIZATION; DISEASE COURSE; EARLY DIAGNOSIS; FECES ANALYSIS; HEPATOBILIARY SCINTISCANNING; HUMAN; IMMUNE RESPONSE; MINIMALLY INVASIVE SURGERY; MORPHOGENESIS; PORTOENTEROSTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SCREENING; VIRUS INFECTION;

BILIARY ATRESIA; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN;

EID: 43449130415     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3282ffdc43     Document Type: Review

References (44)

1. Sokol R, Shepherd R, Superina R, et al. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 2007; 46:566-581.
2. A-Kader H, Balistreri W. Cholestasis. In: Behrman R, Kliegman R, Jenson H, editors. Behrman: Nelson textbook of pediatrics, 17th ed. Philadelphia: Saunders; 2004. pp. 1314-1319.
3. Kasai M, Susuki S. A new operation for 'noncorrectable' biliary atresia: hepatic portoenterostomy. Shujutsu 1959; 13:733-739.
4. Ohi R. Surgery for biliary atresia. Liver 2001; 21:175-182.
5. Chen S, Chang M, Du J, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics 2006; 117:1147-1154.
6. Nwomeh B, Caniano D, Hogan M. Definitive exclusion of biliary atresia in infants with cholestatic jaundice: the role of percutaneous cholecystocholangiography. Pediatr Surg Int 2007; 23:845-849. This study suggests PCC as a modality to rule out biliary atresia.
7. Esmaili J, Izadyar S, Karegar I, Gholamrezanezhad A. Biliary atresia in infants with prolonged cholestatic jaundiced: diagnostic accuracy of hepatobiliary scintigraphy. Abdom Imaging 2006; 32:243-247.
8. Bezerra J. The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia. J Pediatr Gastroenterol Nutr 2006; 43:S23-S29.
9. Jacqumin E, Cresteil D, Raynaud N, Hadchouel M. CFC1 gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 2002; 34:326-327.
10. Davit-Spraul A, Baussan C, Hermeziu B, et al. CFC1 gene involvement in biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 2008; 46:111-112. The authors report further on their experience with the CFC1 gene in the cause of biliary atresia.
11. Shimadera S, Iwai N, Deguchi E, et al. The inv mouse as an experimental model of biliary atresia. J Pediatr Surg 2007; 42:1555-1560. This study suggests a new mouse model for the study of biliary atresia.
12. Hayashida M, Nishimoto Y, Matsuura T, et al. The evidence of maternal microchimerism in biliary atresia using fluorescent in situ hybridization. J Pediatr Surg 2007; 42:2097-2101. This interesting study further describes the role of maternal microchimerism as a potential causal factor in biliary atresia.
13. Kobayashi H, Tamatani T, Tamura T, et al. Maternal microchimerism in biliary atresia. J Pediatr Surg 2007; 42:987-991. This study also describes evidence for the role of microchimerism in the cause of biliary atresia.
14. Mack C. The pathogesesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis 2007; 27:233-242. This important study lays out a strong argument for viral infection in the cause of biliary atresia. Both in-vivo and in-vitro models are discussed and the current evidence for viral infection is summarized.
15. Allen S, Jafri M, Donnelly B, et al. Effect of rotavirus strain on the murine model of biliary atresia. J Virol 2007; 81:1671-1679.
16. Shivakumar P, Campbell K, Sabla G, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004; 114:322-329.
17. Kobayashi H, Tamatani T, Tamura T, et al. The role of monocyte chemoattractant protein-1 in biliary atresia. J Pediatr Surg 2006; 41:1967-1972.
18. Tucker R, Hendrickson R, Mukaida N, et al. Progressive biliary destruction is independent of a functional tumor necrosis factor-alpha pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol 2007; 20:34-43.
19. Mohanty S, Shivakumar P, Sabla G, Bezerra J. Loss if interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol 2006; 19.
20. Mack C, Falta M, Sullican A, et al. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology 2007; 133:278-287. This important study reveals the role of oligoclonal T cells in liver and extra-hepatic bile duct tissue.
21. Shivakumar P, Sabla G, Mohanty S, et al. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 2007; 133:268-277. This study shows that CD8+ T cells have the ability to induce biliary atresia in healthy duct epithelium.
22. Esteves E, Neto E, Neto M, et al. Laparoscopic Kasai portoenterostomy for biliary atresia. Pediatr Surg Int 2002; 18:737-740.
23. Aspelund G, Ling S, Ng V, Kim P. A role for laparoscopic approach in the treatment of biliary atresia and choledochal cysts. J Pediatr Surg 2007; 42:869-872. This study describes the authors' experience in instituting minimally invasive surgery for the treatment of complex hepatic malformations.
24. Dutta S, Woo R, Albanese C. Minimal access portoenterostomy: advantages and disadvantages of standard laparoscopic and robotic techniques. J Laparoendosc Adv Surg Tech 2007; 17:258-264. This study nicely compares what laparoscopic and robotic surgery has to offer in performing a Kasai procedure.
25. Meehan J, Elliott S, Sandler A. The robotic approach to complex hepatobiliary anomalies in children: preliminary report. J Pediatr Surg 2007; 42:2110-2114.
26. Sandler A, Azarow K, Superina R. The impact of previous Kasai procedure on liver transplantation for biliary atresia. J Pediatr Surg 1997; 32:416-419.
27. Davemport M. Biliary atresia. Semin Pediatr Surg 2005; 14:42-48.
28. Shneider B, Brown M, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006; 148:467-474.
29. Petersen C, Harder D, Metler M, et al. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 2007; 102:1-8. This is one of the few prospective studies rigorously looking at a specific post-operative steroid regimen.
30. Rodeck B, Becker A, Gratz K, Peterson C. Early predictors of success of Kasai operation in children with biliary atresia. Eur J Pediatr Surg 2007; 17:308-312. This evaluation of early predictors found bilirubin and HIDA scan to correlate with long-term outcomes.
31. Endo M, Masuyama H, Watanabe K, et al. Calculation of biliary atresia prognostic index using multivariate linear model. J Pediatr Surg 1995; 30:1575-1579.
32. Yanchar N, Shapiro A, Sigalet D. Is early response to portoenterostomy predictive of long-term outcome for patients with biliary atresia? J Pediatr Surg 1996; 31:774-778.
33. Castagnetti M, Davenport M, Tizzard S, et al. Hepatobiliary scintigraphy after Kasai procedure for biliary atresia: clinical correlation and prognostic value. J Pediatr Surg 2007; 42:1107-1113. This study correlates early HIDA results with long-term outcomes. This demonstrates an early tool to identify patients at risk for progressing to transplant.
34. Karrer F, Lilly J. Corticosteroid therapy in biliary atresia. J Pediatr Surg 1985; 20:693-695.
35. Alvaro D, Gigliozzi A, Marucci L, et al. Corticosteroids modulate the secretory processes of the rat intrahepatic biliary epithelium. Gastroenterology 2002; 122:1058-1069.
36. Miner P, Gaito J. Bile flow in response to pharmacologic agents: hepatic DNA as a reference standard. Biochem Pharmacol 1979; 28:1063-1066.
37. Hsieh C, Huang C, Huang L, et al. Glucocorticoid treatment down-regulated chemokine expression of bacterial cholangitis in cholestatic rats. J Pediatr Surg 2004; 39:10-15.
38. Vejchapipat P, Passakonnirin R, Sookpotarom P, et al. High-dose steroids do not improve early outcome in biliary atresia. J Pediatr Surg 2007; 42:2102-2105. This retrospective study with historical controls failed to show a difference in outcomes with postoperative steroids.
39. Escobar M, Jay C, Brooks R, et al. Effect of corticosteroid therapy in outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2006; 41:99-103.
40. Davenport M, Stringer M, Tizzard S, et al. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 2007; 46:1821-1827. This is the only prospective randomized study to date looking at the effectiveness of postoperative steroids. While the steroid regimen is short and the study poorly powered, they are the strongest data available.
41. Stringer M, Davison S, Rajwal S, McClean P. Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg 2007; 42:1324-1328. This retrospective study supports the use of postoperative steroids.
42. Shimadera S, Iwai N, Deguchi E, et al. The significance of steroid therapy after hepatoportoenterostomy in infants with biliary atresia. Eur J Pediatr Surg 2007; 17:100-103.
43. Serinet M, Broue P, Jacquemin E, et al. Management of patients with biliary atresia in France: results of a decentralized policy 1986-2002. Hepatology 2006; 44:75-84.
44. Sibanda N, Lewsey J, van der Meulen J, Stringer M. Continuous monitoring tolls for pediatric surgical outcomes: an example using biliary atresia. J Pediatr Surg 2007; 42:1919-1925. This study demonstrates the use of a potentially useful tool to obtain a more timely assessment of outcomes.